Upstate Active Clinical Trials
Study Title:
AREN1921 - Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)What is the purpose of the study? (in Layman's terms, please describe the study)
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)Upstate Institutional Review Board (IRB) Number:
1716037Study/Protocol ID:
AREN1921Study Phase:
IIPatient Age Group:
ChildrenPrincipal Investigator:
Melanie A ComitoWho is eligible?
Patients must be ≤ 30 years old at study enrollment.What is involved if I participate?
- How long is the study?
until accrual is met - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
surgery, blood draws, radiation therapy, imaging
Where will the study take place?
SUNY Upstate Medical UniversityOther Information:
N/AWho can I contact for more information?
Name: Karen B Bilynsky
Phone: 315-464-7601
Email: [email protected]